Meihua International Medical Technologies, which sells medical supplies around the world, is expected to debut this week on the Nasdaq in New York.
While the amount is relatively small, it would mark the first listing by a Chinese company since October, when biotech firm LianBio raised $334 million on the same exchange, according to data provider Dealogic.
There was just one US IPO from a Chinese company from August through January, compared with 20 in the same time period a year ago, according to Dealogic.
The company went public in June in the biggest US initial public offering by a Chinese firm since Alibaba’s debut in 2014, raising some $4.4 billion.
In December, Didi said it would delist from the New York Stock Exchange and shift its public equity offering to Hong Kong.
Meihua’s upcoming listing in the United States may signal the beginning of a new wave of action, however.
— CNN’s Beijing bureau and Laura He contributed to this report.
Read More: The US is about to get its first Chinese IPO in months from Meihua